We are pleased to announce that the Non-Coding RNA Investigation (NCRI) has received its 2022 CiteScore: 2.8, ranking 312 out of 428 journals in the Biochemistry category.
With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, our editorial office has decided to fully implement the transparent peer review (TPR) process for all new submission from March 15, 2023.
Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Non-coding RNA Investigation (NCRI) is among the list of COPE membership.
On Jun 26, 2021, we received the good news from Elsevier that Non-coding RNA Investigation (NCRI) has been accepted for inclusion in Scopus.
AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020.
Application of the CARE Guideline as reporting standard in Non-coding RNA Investigation
Annual Report of NCRI 2018
Opening Editorial for Non-coding RNA Investigation
1 - 8 of 8 Items